Yue Ma

Dr. Yue Ma

Doshisha University
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2024 in Science Advances
Verified
Journal Article
Open access
BDBo Deng
Bo Deng
YMYue Ma
Yue Ma
JHJialyu Huang
Jialyu Huang
RHRunbang He
Runbang He
MLMiaomiao Luo
Miaomiao Luo
PHPengyu Huang
Pengyu Huang
The utilization of three-dimensional (3D) bioprinting technology to create a transplantable bioartificial liver emerges as a promising remedy for the scarcity of liver donors. This study outlines our strategy for constructing a 3D-bioprinted liver, using in vitro–expanded primary hepatocytes recognized for their safety and enhanced functional robustness as hepatic cell sources for bioartificial liver construction. In addition, we have developed bioink biomaterials with mechanical and rheological properties, as well as printing capabilities, tailored for 3D bioprinting. Upon heterotopic transplantation into the mesentery of tyrosinemia or 90% hepatectomy mice, our 3D-bioprinted liver effectively restored lost liver functions, consequently extending the life span of mice afflicted with liver injuries. Notably, the inclusion of an artificial blood vessel in our 3D-bioprinted liver allowed for biomolecule exchange with host blood vessels, demonstrating, in principle, the rapid integration of the bioartificial liver into the host vascular system. This model underscores the therapeutic potential of transplantation for the treatment of liver failure diseases.

17 August 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MNMasami Noda
Masami Noda
YMYue Ma
Yue Ma
YYYuko Yoshikawa
Yuko Yoshikawa
TITadayuki Imanaka
Tadayuki Imanaka
TMToshiaki Mori
Toshiaki Mori
Kenichi YoshikawaKenichi Yoshikawa
Kenichi Yoshikawa
Dimethyl sulfoxide (DMSO) is widely used as a cryoprotectant for organs, tissues, and cell suspension in storage. In addition, DMSO is known to be a useful free radical scavenger and a radio-protectant. To date, many in vitro assays using cultured cells have been performed for analysing the protective effect of DMSO against genomic DNA damage; however, currently it has been rather difficult to detect DNA double strand breaks (DSBs) in a quantitative manner. In the present study, we aimed to observe the extent of DNA damage by use of single molecular observation with a fluorescence microscope to evaluate DSBs induced by photo- and γ-ray-irradiation, or freeze/thawing in variable concentrations of DMSO. As a result, we found that 2% DMSO conferred the maximum protective effect against all of the injury sources tested, and these effects were maintained at higher concentrations. Further, DMSO showed a significantly higher protective effect against freezing-induced damage than against photo- and γ-ray-irradiation-induced damage. Our study provides significant data for the optimization of DNA cryopreservation with DMSO, as well as for the usage of DNA as the protective agent against the injuries caused by active oxygen and radiations.

28 August 2015 in Chemical Physics Letters
Verified
Journal Article
Open access
PDF file
YMYue Ma
Yue Ma
NONaoki Ogawa
Naoki Ogawa
YYYuko Yoshikawa
Yuko Yoshikawa
TMToshiaki Mori
Toshiaki Mori
TITadayuki Imanaka
Tadayuki Imanaka
Kenichi YoshikawaKenichi Yoshikawa
Kenichi Yoshikawa
The protective effect of ascorbic acid against double-strand breaks in DNA was evaluated by single-molecule observation of giant DNA (T4 DNA; 166 kbp) through fluorescence microscopy. Samples were exposed to three different forms of radiation: visible light, γ-ray and ultrasound. With regard to irradiation with visible light, 1 mM AA reduced the damage down to ca. 30%. Same concentration of AA decreased the damage done by γ-ray to ca. 70%. However, AA had almost no protective effect against the damage caused by ultrasound. This significant difference is discussed in relation to the physico-chemical mechanism of double-strand breaks depending on the radiation source.

17 January 2025 in Journal of Tissue Engineering
Verified
Journal Article
Open access
YMYue Ma
Yue Ma
RHRunbang He
Runbang He
BDBo Deng
Bo Deng
MLMiaomiao Luo
Miaomiao Luo
WZWenjie Zhang
Wenjie Zhang
PHPengyu Huang
Pengyu Huang
The development of advanced in vitro models for assessing liver toxicity and drug responses is crucial for personalized medicine and preclinical drug development. 3D bioprinting technology provides opportunities to create human liver models that are suitable for conducting high-throughput screening for liver toxicity. In this study, we fabricated a humanized liver model using human-induced hepatocytes (hiHeps) derived from human fibroblasts via a rapid and efficient reprogramming process. These hiHeps were then employed in 3D bioprinted liver models with bioink materials that closely mimic the natural extracellular matrix. The constructed humanized 3D bioprinted livers (h3DPLs) exhibited mature hepatocyte functions, including albumin expression, glycogen storage, and uptake/release of indocyanine green and acetylated low-density lipoprotein. Notably, h3DPLs demonstrated increased sensitivity to hepatotoxic agents such as acetaminophen (APAP), making them a promising platform for studying drug-induced liver injury. Furthermore, our model accurately reflected the impact of rifampin, a cytochrome P450 inducer, on CYP2E1 levels and APAP hepatotoxicity. These results highlight the potential of hiHep-based h3DPLs as a cost-effective and high-performance alternative for personalized liver toxicity screening and preclinical drug testing, paving the way for improved drug development strategies and personalized therapeutic interventions.

19 July 2020 in Polymers
Verified
Journal Article
Open access
PDF file
YMYue Ma
Yue Ma
YYYuko Yoshikawa
Yuko Yoshikawa
HOHidehiro Oana
Hidehiro Oana
Kenichi YoshikawaKenichi Yoshikawa
Kenichi Yoshikawa
We measured the changes in the higher-order structure of DNA molecules (λ phage DNA, 48 kbp) at different concentrations of 1- and 2-propanol through single-molecular observation. It is known that 2-propanol is usually adapted for the procedure to isolate genomic DNA from living cells/organs in contrast to 1-propanol. In the present study, it was found that with an increasing concentration of 1-propanol, DNA exhibits reentrant conformational transitions from an elongated coil to a folded globule, and then to an unfolded state. On the other hand, with 2-propanol, DNA exhibits monotonous shrinkage into a compact state. Stretching experiments under direct current (DC) electrical potential revealed that single DNA molecules intermediately shrunk by 1- and 2-propanol exhibit intrachain phase segregation, i.e., coexistence of elongated and compact parts. The characteristic effect of 1-propanol causing the reentrant transition is argued in terms of the generation of water-rich nanoclusters.

12 June 2026 in Science Advances
Verified
Journal Article
Open access
BDBo Deng
Bo Deng
YMYue Ma
Yue Ma
WHWanling Huang
Wanling Huang
XXXiguang Xian
Xiguang Xian
YDYiyi Ding
Yiyi Ding
PHPengyu Huang
Pengyu Huang
The liver is central to drug metabolism and a critical site of disease progression, making vascularized in vitro liver models essential for disease modeling, drug discovery, and mechanistic research. However, recapitulating dynamic in vivo drug responses while maintaining clinical relevance remains a major challenge for bioartificial liver systems. In acute myeloid leukemia (AML), patients frequently develop leukemic liver infiltration and chemotherapy-induced hepatotoxicity, both of which compromise therapeutic efficacy and prognosis. Human-relevant experimental models that dynamically simulate these processes are urgently needed. Here, we developed a dynamic perfusable human vascularized liver module (DPHV-LM), constructed from in vitro–expanded primary human hepatocytes within a perfusable scaffold. Perfusion of AML patient–derived cells reproduced leukemic infiltration of liver tissue. Using the DPHV-LM for drug screening and validating findings in AML mouse models, we identified ammonium glycyrrhizinate (AMGZ) as an agent that reduces cytarabine-induced hepatotoxicity and suppresses leukemic infiltration without impairing antileukemic efficacy. The hepatoprotective trends observed in the DPHV-LM were qualitatively concordant with findings from an independent retrospective clinical cohort. Collectively, these results demonstrate the transplantational potential of this platform for modeling leukemic liver pathology and for the development of hepatoprotective therapeutic strategies.